Abstract
NPM1 mutation and leukemia-specific fusion transcript RUNX1-RUNX1T1 are the predictors of favorable prognosis (DFS and OS). Nevertheless, a substantial proportion of this patients show disease relapses. It is necessary to identify negative prognostic factors for pts with NPM1mut and RUNX1-RUNX1T1 and evaluate if ASCT could overcome them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
